Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study

This publication has 44 references indexed in Scilit:

• Depression and Anxiety Disorders among Patients with Psoriasis: A Hospital-Based Case-Control Study
  Dermatology Research and Practice, 2012
• Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
  Journal of the American Academy of Dermatology, 2010
• The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis
  Archives of Dermatology, 2010
• Combined effects of HLA‐Cw6 and cigarette smoking in psoriasis vulgaris: A hospital‐based case–control study in China
  Journal of the European Academy of Dermatology and Venereology, 2009
• Common Chronic Pain Conditions in Developed and Developing Countries: Gender and Age Differences and Comorbidity With Depression-Anxiety Disorders
  The Journal of Pain, 2008
• Psychological Predictors of Prognosis in Chronic Heart Failure
  Journal of Cardiac Failure, 2008
• Screening for mental disorders in laryngeal cancer patients: a comparison of 6 methods
  Psycho-Oncology, 2007
• Pathogenesis and clinical features of psoriasis
  The Lancet, 2007
• HLA-Cw6-Positive and HLA-Cw6-Negative Patients with Psoriasis Vulgaris have Distinct Clinical Features
  Journal of Investigative Dermatology, 2002
• The Hospital Anxiety and Depression Scale
  Acta Psychiatrica Scandinavica, 1983